References
- Qiu M, Shields CL. Choroidal nevus in the United States adult population: racial disparities and associated factors in the national health and nutrition examination survey. Ophthalmology. 2015;122:2071–2083.
- Sumich P, Mitchell P, Wang JJ. choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophtalmol. 1998;116:645–650.
- Vajdic CM, Kricker A, Giblin M, et al. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer. 2003;105:117–122.
- Keenan TD, Yeates D, Goldacre MJ. Uveal melanoma in England: trends over time and geographical variation. Br J Ophthalmol. 2012;96:1415–1419.
- Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651–4659.
- Burr JM, Mitry E, Rachet B, et al. Survival from uveal melanoma in England and Wales 1986 to 2001. Ophthalmic Epidemiol. 2007;14:3–8.
- Damato BE, Heimann H, Kalirai H, et al. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 2014;132:605–613.
- Khan J, Damato BE. Accuracy of choroidal melanoma diagnosis by general ophthalmologists: a prospective study. Eye (Lond). 2007;21:595–597.
- Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119:1582–1589.
- Damato B. Time to treatment of uveal melanoma in the United Kingdom. Eye (Lond). 2001;15:155–158.
- Shields CL, Dalvin LA, Ancona-Lezama D, et al. Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina. 2019;39:1840–1851.
- Roelofs K, Weis E. Tele-Oncology: a validation study of choroidal and iris nevi. Ocul Oncol Pathol. 2019;5:298–302.
- Roelofs KA, O’Day R, and Harby LA, et al. The MOLES System for planning management of melanocytic choroidal tumors: is it safe? Cancers (Basel). 2020;12:1311.
- Roelofs KA, O’Day R, Al Harby L, et al. Detecting progression of melanocytic choroidal tumors by sequential imaging: is ultrasonography necessary? Cancers (Basel). 2020;12:1856.
- Salehi O, van Wijngaarden P, and Keel S, et al. Estimating malignancy risk of melanocytic choroidal tumours detected in the Australian National Eye Health Survey. Clin Exp Optometry. 2021;104:854–858.
- Al Harby L, Sagoo MS, and O’Day R, et al. Distinguishing choroidal nevi from melanomas using the MOLES algorithm: evaluation in an ocular nevus clinic. Ocul Oncol Pathol. 2021:7:294-302.
- Kiely PM, Cappuccio S, McIntyre E. Optometry Australia scope of practice survey 2015. Clin Exp Optom. 2017;100:260–269.
- Hemmerdinger C, Beech M, Groenewald C, et al. Validation of an online referral guide for melanocytic fundus lesions. Ophthalmic Physiol Opt. 2011;31:574–579.
- Al Harby L, Ali Z, and Rajai A, et al. Prospective validation of a virtual clinic pathway in the management of choroidal naevi: the NAEVUS study Report no. 1: safety assessment. Br J Ophthalmol. 2020;106:128-134.
- LLC CND. Eye handbook. Apple App Store. Kansas, US; 2021. p iPadOS 12.10; iOS 12.10.
- LLC CND. Eye handbook. Google Play App Store. Kansas, US; 2021. p Android 4.2.
- Zarwell T. EyeDock. Apple App Store. Wisconsin, US; 2021. p iOS 6.0